ALPHAONE FUNDAMENTAL MICRO CAP CORE

Strategy & Objective

The investment team, led by Senior Portfolio Manager Daniel Goldfarb, employ a fundamentally-driven, growth-at-a-reasonable price investment philosophy when targeting U.S. micro cap companies with competitive positions, and the potential for sustained growth over the next several years.


Annual Returns


FACT SHEET

The performance data quoted represents past performance. Past performance does not guarantee future results.

The Russell 2000 Index measures the performance of the small-cap segment of the U.S. equity universe. The Russell 2000 Index performance quoted is shown for illustrative purposes only, does not represent actual account performance and is not meant to forecast, imply or guarantee future account performance. An index is unmanaged and cannot be invested in directly. Performance data for the indices is gross and does not reflect and deduction for fee, transaction costs or other expenses that an investor would pay if invested in an account directly.

All data as of prior quarter end, and all returns are net-of-fees.

Data provided by FactSet.

Strategy Details
Strategy Equity Long
Benchmark Russell 2000
Inception 4/30/1994
Turnover 65
Weighted Avg Mkt Cap $1012M
Investment Team
Daniel Goldfarb Sr Portfolio Mgr
Steven Dray Senior Portfolio Mgr
Christopher Crooks Portfolio Mgr
Constantine Davides Senior Healthcare Analyst

Top 5 Holdings
Knight Transportation, Inc.3.04%
AMAG Pharmaceuticals, Inc.3.01%
Cambrex Corp.2.42%
Old Dominion Freight Line, Inc.2.40%
Cardiome Pharma. Corp.2.37%

Annual Returns




Trailing Returns (Periods greater than one years are annualized)


FACT SHEET

The performance data quoted represents past performance. Past performance does not guarantee future results.

The Russell 2000 Index measures the performance of the small-cap segment of the U.S. equity universe. The Russell 2000 Index performance quoted is shown for illustrative purposes only, does not represent actual account performance and is not meant to forecast, imply or guarantee future account performance. An index is unmanaged and cannot be invested in directly. Performance data for the indices is gross and does not reflect and deduction for fee, transaction costs or other expenses that an investor would pay if invested in an account directly.

All data as of prior quarter end, and all returns are net-of-fees.

Data provided by FactSet.

Return Analysis3YR5YR
Annualized return17.216.1
Total return60.9111.2
Average return1.41.4
Avg upmarket return3.34.1
Avg downmarket return(2.41)(3.0)
Downside capture84.883.7
Upside capture81.577.8
Risk Analysis3YR5YR
Annualized stdev12.2215.67
Upside deviation11.3613.33
Downside deviation6.569.16
MPT Statistics3YR5YR
Alpha1.843.17
Beta0.820.81
Correlation0.880.94
Sharpe ratio1.41.04

Sector Composition**




Value & Growth Characteristics**Fundamental Micro Cap CoreRussell 2000
Price/Earnings16.017.2
Price/Book2.72.2
Price/Sales2.82.0
Price/Cash Flow13.912.8
ROA9.04.9
ROE15.18.4

FACT SHEET

The performance data quoted represents past performance. Past performance does not guarantee future results.

The Russell 2000 Index measures the performance of the small-cap segment of the U.S. equity universe. The Russell 2000 Index performance quoted is shown for illustrative purposes only, does not represent actual account performance and is not meant to forecast, imply or guarantee future account performance. An index is unmanaged and cannot be invested in directly. Performance data for the indices is gross and does not reflect and deduction for fee, transaction costs or other expenses that an investor would pay if invested in an account directly.

All data as of prior quarter end, and all returns are net-of-fees.

Data provided by FactSet.

Asset Allocation**
Market Cap Exposure**
Top 10 Holdings*
Knight Transportation, Inc.3.04%
AMAG Pharmaceuticals, Inc.3.01%
Cambrex Corp.2.42%
Old Dominion Freight Line, Inc.2.40%
Cardiome Pharma. Corp.2.37%
Vascular Solutions, Inc.2.32%
U.S. Physical Therapy, Inc.2.31%
CECO Environmental Corp.2.25%
Natus Medical Inc.2.20%
Renasant Corp.2.08%